Health Condition 1: E282- Polycystic ovarian syndrome Health Condition 2: E282- Polycystic ovarian syndrome
Conditions
Interventions
Intervention1: Individualized homeopathic similimum.: Indicated Homeopathic medicines in various potencies strictly adhering to homeopathic principles. Daily, weekly, or monthly repetition of dose as
Sponsors
MNR Homoeopathic Medical college
Eligibility
Inclusion criteria
Inclusion criteria: Female patients from 18-35 years who fulfil the Rotterdams criteria for PCOS. Known Cases of PCOS with history of PCOS for at least more than 3 months to rule out spontaneous, natural regression of functional cysts. All patients with positive finding of Polycystic ovaries in ultrasound scan, clinical hyperandrogenism and menstrual irregularities oligo or amenorrhea, will be included in the study. In the beginning of study, each case will be investigated with Abdominopelvic ultrasound scan, FSH, LH, Prolactin & Thyroid profile. A checklist for clinical record will be created to exclude Cushings syndrome, Congenital adrenal hyperplasia, Hyperprolactinemia, Hyperthecosis & Diabetes mellitus. If at all indications of other disease is evident then such cases will not be considered for the study. Patients who are willing to give written informed consent for research participation will be included in the study.
Exclusion criteria
Exclusion criteria: Patients with masculine tumours of adrenal gland or ovary will be excluded. Patients with Congenital adrenal hyperplasia, Cushing s syndrome, Hyperprolactinemia, Hyperthecosis are excluded from the study. Patients with Hypothyroidism, Hyperthyroidism, Diabetes mellitus are also excluded. PCOS patients with endometrial cancer, Hypertension & other severe cardiovascular complications are excluded from the study. Patients with other systemic illness are excluded from study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in ovarian morphology, assessed by ultrasonography, measured as change in number of follicles and ovarian volume from baseline to the end of the treatment period, following intervention of individualized homoeopathic similimum by utilising the mind chapter from Murphys repertory.Timepoint: Follow-up assessment will be conducted periodically throughout the study period. Patients will be seen every 15 days till menses are regularized. Then onwards every monthly follow-up for symptomatic analysis. USG done before treatment & then onwards every 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| The outcome of the study may help us to understand the utility and gaps in representation of rubrics and thus bridge the gap that exist in Murphy s repertoryTimepoint: Will be assessed throughout the research study period. | — |
Countries
India
Contacts
Public ContactDR Anoop Nigwekar
Dr. M. L. Dhawale Memorial Homoeopathic Institute
Outcome results
None listed